Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES)

Addiction
Rebecca McKetinAbdullah Mamun

Abstract

To evaluate the impact of community-based drug treatment on methamphetamine use using inverse probability of treatment-weighted (IPTW) estimators to derive treatment effects. A longitudinal prospective cohort study with follow-ups at 3 months, 1 year and 3 years. Treatment effects were derived by comparing groups at follow-up. IPTW estimators were used to adjust for pre-treatment differences between groups. Sydney and Brisbane, Australia. Participants were methamphetamine users entering community-based detoxification (n = 112) or residential rehabilitation (n = 248) services and a quasi-control group of methamphetamine users (n = 101) recruited from the community. Frequency of methamphetamine use between interviews (no use, less than weekly, 1-2 days per week, 3+ days per week), continuous abstinence from methamphetamine use, past month methamphetamine use and methamphetamine dependence. Detoxification did not reduce methamphetamine use at any follow-up relative to the quasi-control group. Relative to quasi-control and detoxification groups combined, residential rehabilitation produced large reductions in the frequency of methamphetamine use at 3 months [odds ratio (OR) = 0.23, 95% confidence interval (CI) 0.15-0.36, P < 0.001)...Continue Reading

References

Nov 1, 1982·Psychological Medicine·L N RobinsW Seyfried
Mar 21, 1998·Social Psychiatry and Psychiatric Epidemiology·G Andrews, L Peters
Oct 27, 1998·Drug and Alcohol Dependence·S Darke
Jan 5, 2000·Drug and Alcohol Dependence·P M FlynnR L Hubbard
Feb 26, 2000·Forensic Science International : Synergy·R Wennig
Jul 25, 2000·Journal of Psychoactive Drugs·M L BrechtM D Anglin
Aug 24, 2000·Epidemiology·J M RobinsB Brumback
Apr 23, 2002·The Journal of Mental Health Policy and Economics·William S. Cartwright
Dec 13, 2003·Journal of Substance Abuse Treatment·Robert L HubbardJill Anderson
May 14, 2004·Addiction·Richard A RawsonUNKNOWN Methamphetamine Treatment Project Corporate Authors
Jun 19, 2004·The American Journal on Addictions·Joan E ZwebenUNKNOWN Methamphetamine Treatment Project
Sep 15, 2005·BMC Medical Research Methodology·M Höfler
Jun 29, 2007·Journal of Chromatography. a·Hajime MiyaguchiHiroyuki Inoue
Jan 9, 2008·BMC Psychiatry·Ilya LipkovichJohn P Houston
Feb 26, 2008·Journal of Substance Abuse Treatment·Suzette Glasner-EdwardsUNKNOWN Methamphetamine Treatment Project Corporate Authors
Apr 14, 2009·The Journal of Nervous and Mental Disease·Suzette Glasner-EdwardsUNKNOWN Methamphetamine Treatment Project Corporate Authors
Mar 1, 2009·The American Economic Review·Carlos Dobkin, Nancy Nicosia
Jul 24, 2010·Lancet·Grant ColfaxCarl Hart
Aug 19, 2010·The American Journal on Addictions·Suzette Glasner-EdwardsUNKNOWN Methamphetamine Treatment Project Corporate Authors
Sep 29, 2010·Journal of Health Communication·UNKNOWN United Nations Economic and Social Council (ECOSOC)

❮ Previous
Next ❯

Citations

Mar 13, 2014·Chemical Communications : Chem Comm·K C CollinsK D Janda
Dec 10, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Joshua L GowinMartin P Paulus
Jan 15, 2013·Journal of Substance Abuse Treatment·Mary-Lynn BrechtDarren Urada
Dec 3, 2014·Brain Research·Edythe D LondonMichael E Ballard
Feb 24, 2015·Australian Journal of Primary Health·Sarah MacLeanKerry Arabena
May 24, 2015·Current Opinion in Psychiatry·Nadine EzardKate Dolan
Apr 8, 2016·Journal of Medicinal Chemistry·Karen C CollinsKim D Janda
Feb 14, 2015·Psychiatry Research·Leanne HidesJohn B Saunders
Jun 1, 2016·Drug and Alcohol Review·Rebecca McKetinMichael Berk
Aug 4, 2016·Drug and Alcohol Dependence·Allyson L SpenceNicholas E Goeders
Aug 23, 2016·Frontiers in Neuroendocrinology·Sarah J Baracz, Jennifer L Cornish
Jan 11, 2017·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Shalini ArunogiriDan I Lubman
Jan 16, 2016·The Australian and New Zealand Journal of Psychiatry·Victoria ManningDan I Lubman
Mar 20, 2018·The Australian and New Zealand Journal of Psychiatry·Grant SaraJulia Lappin
Aug 24, 2017·Journal of Forensic Sciences·Shane DarkeJohan Duflou
May 24, 2014·Substance Abuse : Research and Treatment·Mary-Lynn Brecht, Diane M Herbeck
Jun 10, 2015·Substance Abuse : Research and Treatment·Catherine ArseneaultMichel Rousseau
Aug 25, 2017·Journal of Neurology, Neurosurgery, and Psychiatry·Julia M LappinMichael Farrell
Aug 22, 2018·Qualitative Health Research·Laura HoffmannMatthias Richter
Feb 15, 2018·Suicide & Life-threatening Behavior·Shane DarkeJulia Lappin
Nov 1, 2018·Journal of Addiction Medicine·Chloe LanyonBrendan Quinn
Jul 20, 2019·Addiction·Julia M Lappin, Grant E Sara
Jun 24, 2020·Drug and Alcohol Review·Rachel ReillyUNKNOWN on the behalf of the NIMAC Community Researchers and Partner Sites
Jan 11, 2020·Frontiers in Psychiatry·Shalini ArunogiriDan I Lubman
Mar 5, 2016·The Medical Journal of Australia·Louisa DegenhardtRebecca McKetin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.